CA2294841A1 - Preloaded implantation device - Google Patents
Preloaded implantation device Download PDFInfo
- Publication number
- CA2294841A1 CA2294841A1 CA002294841A CA2294841A CA2294841A1 CA 2294841 A1 CA2294841 A1 CA 2294841A1 CA 002294841 A CA002294841 A CA 002294841A CA 2294841 A CA2294841 A CA 2294841A CA 2294841 A1 CA2294841 A1 CA 2294841A1
- Authority
- CA
- Canada
- Prior art keywords
- plunger
- chamber
- needle
- implant
- channel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000002513 implantation Methods 0.000 title claims abstract description 28
- 239000007943 implant Substances 0.000 claims abstract description 49
- 238000002156 mixing Methods 0.000 claims abstract description 3
- 210000001519 tissue Anatomy 0.000 description 7
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229930182833 estradiol Natural products 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 206010033675 panniculitis Diseases 0.000 description 3
- 210000004304 subcutaneous tissue Anatomy 0.000 description 3
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- -1 PPMA Polymers 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 210000003815 abdominal wall Anatomy 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000012173 estrus Effects 0.000 description 1
- GCKFUYQCUCGESZ-BPIQYHPVSA-N etonogestrel Chemical compound O=C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 GCKFUYQCUCGESZ-BPIQYHPVSA-N 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 229940044513 implanon Drugs 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000009806 oophorectomy Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0069—Devices for implanting pellets, e.g. markers or solid medicaments
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Prostheses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Disclosed is an implantation device (1) comprising a hollow needle (2), preferably of the type having a chamfered tip profile, and a body (3) adjoining the needle part comprising a plunger (5), preferably having a chamfered tip profile capable of blending with the needle tip profile. The device is made preloadable by being provided with a chamber (7) capable of holding an implant (8), which chamber is positioned radially outside the periphery of the plunger (5) and has a directly or indirectly open connection to a channel (6) surrounding the plunger. The plunger is capable of closing off and opening up the chamber by being displaced.
Description
PRELOADED IMPLANTATION DEVICE
The invention pertains to a pre-loadable implantation device comprising a hollow needle and a body adjoining the needle, the body comprising an elongated part extending along the same axis as the needle, a plunger that can be displaced within the elongated part and the needle, the periphery of the plunger defining a channel in the elongated part, and a chamber capable of holding an implant. The invention also pertains to an implantation device that has actually been preloaded with an implant.
Implantation devices are known and serve to introduce a medicinal implant (small rod, pill, tablet, granule and the like which incorporates a pharmaceutically active substance) subcutaneously into humans or animals, or into subcutaneous tissue of humans or animals in an easy, effective and aseptic way.
The implanting of a pharmaceutical preparation subcutaneously or in subcutaneous tissue is normally used in human and veterinary medicine to achieve, e.g., prolonged action of the pharmacon. The implant introduced (small rod, pill, tablet, granule, etc.) slowly dissolves in the surrounding tissue or slowly releases the pharmacon thereto, and the pharmacon goes into circulation via the blood or the lymph in order then to be transported to the site or sites where it can perform its action.
Thus, for example, in gynaecolo<~y a tablet containing an oestrogen, for example oestradiol, is implanted in women after double ovariectomy or in women during menopause in order to counteract or prevent certain symptoms from which these women suffer or may suffer. Such oestradiol, or other gynaecological implants are generally inserted subcutaneously into an area where there is relatively little movement, such as the upper outer quadrant of the buttock or the lower abdominal wall. In animals implants which contain hormones are, for example, introduced subcutaneously in order to regulate oestrus.
The invention, as noted above, is in the field of preloadable implantation devices.
The term "preloadable" indicates that the device allows the implant to be present within the device before such device is used. i.e. by comprising a chamber capable of holding, an implant. Such a chamber, which may have any shape suitable for any desired implant to fit into it, when provided beforehand with the implant (i.e. in the preloaded state) makes it easier to control the desired sterility.
Particularly, the invention thus provides easy handling by a specialist or a general practitioner, as well as an easy administration per se of the implant: this can be done by simply pushinV.: forward the plunger so as to displace it into the needle and thus insert the implant throu~~h the needle into the body.
Preloadable implantation devices of the aforementioned type are known. Thus, e.g.
US 5,~?0,660 discloses a device for administering implants, which comprises an active substance container with injection cannula and plunger. The plunger is arranv_ed in a plun~,~er channel which merges into the lumen of the cannula. A
holder-device for the implant is arranged at the lumen-end side of the plunger channel.
Another background art reference on preloaded implantation devices is EP 402 955, which discloses a syringe containing a capsule chamber, a hollow needle (removably) mounted at the front end of the capsule chamber, and a plunger, all mounted on a common axis so that the plunger can be passed through the capsule chamber and into the hollow needle to expel a capsule of a solid preparation from the chamber throu~~h the needle into a patients body.
Other disclosures on preloaded implantation devices having, positioned in line, a hollow needle, an implant-containing chamber and a plunger by means of which the implant can be pushed throu~,;h the needle, include US 4,661,103, US
4,601,699, GB 2-13S-298, EP 551 699, and FR 2,231,355.
The present invention provides an implantation device with which not only the above problems are solved, but which also avoids the drawbacks of more old-fashioned methods of subcutaneously introducing tablets containing an active substance. .=1 known implantation device serving this purpose, has bene described in EP 564 038. A major drawback of the above preloadable implantation devices is that they do not enjoy the benefits associated with the implantation device accordin<, to EP 564 038.
To have these benefits, it must be possible for the needle to be chamfered at the distal end {tip), specifically in such a way that there is a sharp point with which the skin can be pierced, and is firmly joined at the proximal end to the body. The plunger too (also referred to as a mandrel) has a distal end (tip) which is chamfered, specifically at precisely the same angle as the hollow needle. Thus the plunger can be pushed into the hollow needle in such a way that the chamfered end precisely coincides with the chamfered end of the hollow needle, as a result of which a solid needle is, as it were, produced. With the solid needle formed in this way, the skin and the subcutaneous tissue is pricked at the site where it is desired to introduce the implant, normally at an oblique angle. The advantage of using a chamfered solid needle is that the tissue is split and not punched. As a result, the tissue is damaged to a lesser ement and the healing of the prick proceeds more quickly, virtually without leavin<, anv scar. With a hollow chamfered needle, there is a greater possibility in that some tissue will enter the needle as a result of the punching action, the tissue damage therefore becomes somewhat greater and the healing of the prick lasts somewhat loner, with a greater probability of some visible scar.
The above-described preloadable implantation devices cannot be made to have such a provision. For, the plunger essentially must be in the pushed forward position (so as to enable the chamfered plunger tip to blend with the chamfered needle tip) when a patient is pierced with the needle. In the prior art devices this cannot be done without untimely displacing the implant from the chamber to outside the needle tip.
In EP 564 038. a way of operation has been disclosed which involves placing the implant into a chamber during use of the device, e.g. in a rather precise operation usin<~ tweezers. Other disclosures on implantation devices that require loading of the implant duriny~ operation include US 1,789,766, US 3,921,632 and DE 806 702.
None of these known devices has a chamber capable of holding the implant. This also holds for other known injection devices which have specially designed needle-tips for which, by way of background, reference is made to US 2,751,907 and GB
The invention pertains to a pre-loadable implantation device comprising a hollow needle and a body adjoining the needle, the body comprising an elongated part extending along the same axis as the needle, a plunger that can be displaced within the elongated part and the needle, the periphery of the plunger defining a channel in the elongated part, and a chamber capable of holding an implant. The invention also pertains to an implantation device that has actually been preloaded with an implant.
Implantation devices are known and serve to introduce a medicinal implant (small rod, pill, tablet, granule and the like which incorporates a pharmaceutically active substance) subcutaneously into humans or animals, or into subcutaneous tissue of humans or animals in an easy, effective and aseptic way.
The implanting of a pharmaceutical preparation subcutaneously or in subcutaneous tissue is normally used in human and veterinary medicine to achieve, e.g., prolonged action of the pharmacon. The implant introduced (small rod, pill, tablet, granule, etc.) slowly dissolves in the surrounding tissue or slowly releases the pharmacon thereto, and the pharmacon goes into circulation via the blood or the lymph in order then to be transported to the site or sites where it can perform its action.
Thus, for example, in gynaecolo<~y a tablet containing an oestrogen, for example oestradiol, is implanted in women after double ovariectomy or in women during menopause in order to counteract or prevent certain symptoms from which these women suffer or may suffer. Such oestradiol, or other gynaecological implants are generally inserted subcutaneously into an area where there is relatively little movement, such as the upper outer quadrant of the buttock or the lower abdominal wall. In animals implants which contain hormones are, for example, introduced subcutaneously in order to regulate oestrus.
The invention, as noted above, is in the field of preloadable implantation devices.
The term "preloadable" indicates that the device allows the implant to be present within the device before such device is used. i.e. by comprising a chamber capable of holding, an implant. Such a chamber, which may have any shape suitable for any desired implant to fit into it, when provided beforehand with the implant (i.e. in the preloaded state) makes it easier to control the desired sterility.
Particularly, the invention thus provides easy handling by a specialist or a general practitioner, as well as an easy administration per se of the implant: this can be done by simply pushinV.: forward the plunger so as to displace it into the needle and thus insert the implant throu~~h the needle into the body.
Preloadable implantation devices of the aforementioned type are known. Thus, e.g.
US 5,~?0,660 discloses a device for administering implants, which comprises an active substance container with injection cannula and plunger. The plunger is arranv_ed in a plun~,~er channel which merges into the lumen of the cannula. A
holder-device for the implant is arranged at the lumen-end side of the plunger channel.
Another background art reference on preloaded implantation devices is EP 402 955, which discloses a syringe containing a capsule chamber, a hollow needle (removably) mounted at the front end of the capsule chamber, and a plunger, all mounted on a common axis so that the plunger can be passed through the capsule chamber and into the hollow needle to expel a capsule of a solid preparation from the chamber throu~~h the needle into a patients body.
Other disclosures on preloaded implantation devices having, positioned in line, a hollow needle, an implant-containing chamber and a plunger by means of which the implant can be pushed throu~,;h the needle, include US 4,661,103, US
4,601,699, GB 2-13S-298, EP 551 699, and FR 2,231,355.
The present invention provides an implantation device with which not only the above problems are solved, but which also avoids the drawbacks of more old-fashioned methods of subcutaneously introducing tablets containing an active substance. .=1 known implantation device serving this purpose, has bene described in EP 564 038. A major drawback of the above preloadable implantation devices is that they do not enjoy the benefits associated with the implantation device accordin<, to EP 564 038.
To have these benefits, it must be possible for the needle to be chamfered at the distal end {tip), specifically in such a way that there is a sharp point with which the skin can be pierced, and is firmly joined at the proximal end to the body. The plunger too (also referred to as a mandrel) has a distal end (tip) which is chamfered, specifically at precisely the same angle as the hollow needle. Thus the plunger can be pushed into the hollow needle in such a way that the chamfered end precisely coincides with the chamfered end of the hollow needle, as a result of which a solid needle is, as it were, produced. With the solid needle formed in this way, the skin and the subcutaneous tissue is pricked at the site where it is desired to introduce the implant, normally at an oblique angle. The advantage of using a chamfered solid needle is that the tissue is split and not punched. As a result, the tissue is damaged to a lesser ement and the healing of the prick proceeds more quickly, virtually without leavin<, anv scar. With a hollow chamfered needle, there is a greater possibility in that some tissue will enter the needle as a result of the punching action, the tissue damage therefore becomes somewhat greater and the healing of the prick lasts somewhat loner, with a greater probability of some visible scar.
The above-described preloadable implantation devices cannot be made to have such a provision. For, the plunger essentially must be in the pushed forward position (so as to enable the chamfered plunger tip to blend with the chamfered needle tip) when a patient is pierced with the needle. In the prior art devices this cannot be done without untimely displacing the implant from the chamber to outside the needle tip.
In EP 564 038. a way of operation has been disclosed which involves placing the implant into a chamber during use of the device, e.g. in a rather precise operation usin<~ tweezers. Other disclosures on implantation devices that require loading of the implant duriny~ operation include US 1,789,766, US 3,921,632 and DE 806 702.
None of these known devices has a chamber capable of holding the implant. This also holds for other known injection devices which have specially designed needle-tips for which, by way of background, reference is made to US 2,751,907 and GB
2,199,247.
As will be clear from the above, with the present invention it is sought to provide an implantation device which can be preloaded, thus making it possible to avoid the step of loading the device with the implant during use, but at the same time has the possibility of being provided with provisions that require the free displaceability of the plunger, such as a plunger which blends with the tip o f the needle, so as to avoid undue damage to the patient's tissue.
This object is fulfilled by the invention. To this end, the invention consists therein, that in an implantation device of the above-identified, preloadable type, the chamber is positioned r adiallv outside the channel and has a directly or indirectly open connection to the channel, the plunger being capable of closing off and opening up the chamber by bein<T displaced.
Although benefits of the present invention can be enjoyed in the case of implantation devices that neither have a chamfered needle tip, nor a chamfered plunger tip, it will be clear that it is preferred according to the invention to have such provisions. In that respect, the invention provides a particular improvement on implantation devices such as described in EP 564 038, US 3,921,632.
Essentially, this is the type of devices which comprises a hollow needle with a chamfered tip profile and a body adjoining the needle part, the body comprising (a) an elongated part extending along the same axis as the needle, (b) a plunger that can be displaced within the elongated pan and the needle, the plunger having a chamfered tip profile capable of blending with the needle tip profile, wherein the periphery of the plunger defines a channel in the elongated part, and (c) a chamber capable of holding an implant. The chamber of these known devices not being preloadable, the present invention solves the problem of how to provide a preloadable device without losing the strong; benefit of the chamfered plunger profile. As outlined above, the means to solve this problem is that the device is provided with a chamber that is positioned radially outside the channel and has a directly or indirectly open connection to the channel, whereby the plunger is capable of closing off and opening up the chamber by being displaced.
The closing ot~ an opening up of the chamber can be by simple displacement of the plun'.:er. l.e., the chamber has an opening of such dimensions at the side of the plunger that, when the plunger is pulled back to behind the chamber (i.e. is pulled to the rear end of the device, by which is meant the end facing away from the needle), an implant contained within the chamber will automatically fall into the plunger channel. It is also possible to make use of other forces than that of gravity, e.g. by providing the chamber, at the side facing away from the channel, with an elastic means such as a spring, which pushes the implant against the plunger when the chamber is closed off and which makes the implant be pushed from the chamber into the channel when the plunger has been pulled back. Other means for the closing ofd of the chamber than just the plunger can be provided. Thus, other possibilities include a chamber closed off by an additional closing means, such as a door which automatically opens upon full withdrawal of the plunger, or any suitable mechanical, electronic or optical means steering the opening up of the chamber so that an implant contained therein can be displaced into the channel on or after the moment that the required space therein has become available by withdrawal of the plunger.
The requirement of the plun~,;er being capable of closing off' and opening up the chamber by being displaced not only refers to the way the open connection between the chamber and the channel has been made, it also refers to the longitudinal position of the chamber and the length of the plunger. It will be clear to the person of ordinaw skill in the art, that the plunger should be long enough to be pulled back to behind the chamber, and that it is preferred for the chamber to be at a sufficiently large distance from the rear end of the device so as to allow the plunger to be pulled back sufhicientlv and still be contained within the body of the device.
S
The device may contain suitable means to ensure that when the plunger is pushed fully into the needle, the chamfered needle point and the chamfered end of the mandrel coincide precisely. Possible means for providing this include a plunger end (i.e. at the side facing away from the needle) of in itself conventional type, which has a lamer diameter than the plunger channel, and thus will prevent the plunger from beinv; pushed forward any further than to the point at which said plunger end bumps against the plunger channel. Other means include a protrusion on the plunger and corresponding insertion in the wall of the plunger channel, or vice-versa, designed at such a position that when the plunger has been pushed forward to the 1S desired distance, the protrusion will be fixed into the insertion (comparable to a principle known from an unrelated art, viz. that of well-known ball-points of the BIC~ type).
As mentioned above, the chamber has a position radially outside the channel.
In ~~eneral, this means that the chamber has a position which, when the device is being used to administer an implant, can be described as being "above" the channel.
By virtue of the direct or indirect open connection of the chamber to the channel, an implant contained within the chamber will actually fall into the channel (as a result of the action of gravity) when the plunger has been withdrawn (pulled backwards) 2S so as to free the part of the channel directly underneath the chamber.
Other embodiments. though, are not to be excluded, e.g. a chamber which has a position which, upon use of the device, can be described as being "underneath" the channel and which comprises a spring or the like which may forward an implant into the channel.
In the case of a needle having the, most preferable, chamfered tip and associated chamfered plunger, the device is asymmetric in respect of a virtual central axis.
Thus a "bottom" and a "top" side of the device can be defined. In respect thereof, a preferred embodiment is as follows. Considering that the point of the chamfered S needle, and consequently also the point of the chamfered plunger, preferably are situated at the bottom side, it is preferred for the chamber capable of holding the implant to be situated at the top side.
The component parts of the device according to the invention and the feeding of a preloaded implant is further explained hereinafter with reference to the schematic drawings.
The figures each depict, in longitudinal cross-section, a device according to the invention. The reference signs in each of the figures having the same meaning, all of the fi~,;ures display an implantation device (I) having a hollow needle (2) and a body (3) adjoining the needle (2) the body comprising an elongated pan (4) extending along the same axis as the needle (2), a plunger (5) that can be displaced within the elongated part (4) and the needle (2), the periphery of the plunger defining a channel (G) in the elongated part (4), and a chamber (7) capable of holding an implant (8).
In FIG.1 a device ( 1 ) is shown in which the chamber (7) containing the implant (8) is in the closed-off position. FIG.2 shows a device ( 1 ) in which the chamber (7) has been opened up by pulling back the plunger (5) and the implant (8) has been fed into the channel (6). FIG.3 is incorporated to show the further operation of the device ( I ), viz. the pushing forward of the implant (8) by means of the plunger (5).
The components of the device are generally made of a hard material, for example stainless steel. Certain parts of the device may also be made of a suitable plastic, for example a hard type of PVC, certain nylons, PTFE, acrylates such as PPMA, polypropene, polystyrene, polycarbonate or polyoxymethylene. Preferred synthetic materials are those that are sterilisable, more particularly those that may withstand y-sterilisation. Such materials are known to the person of ordinary skill in the art.
Preferred synthetic materials are ABS (terpolymer of acrylonitrile, butadiene, and styrene) and SAN (copolymer of styrene and acrylonitrile). Without excluding the possibilities of using other than conventional materials for the needle part and said elongated part, or at least the distal parts thereof, these are generally made of metal, preferably stainless steel. The implantation devices of the invention can be manufactured using conventional techniques known to the person skilled in the art.
The body, which may serve as a handle part or may comprise an additional handle part, is thicker than the needle part and may be tubular, but it may also have a different cross section. The handle part should, of course, have a shape such that the device can easily be handled for the purpose for which the device is intended.
Thus, recesses can be provided in which the fingers, for example thumb and index finer, fit in order to enable the device to be held firmly during use.
The implants to be contained witi>in the chamber, and, consequently, the chamber itself, may have any shape. A frequently occurring shape is that of a rod of cylindrical or rectangular cross-section, such as in the case of an implantation tablet which contains oestradiol and which is made under the brand name Dimenformon by N. V. Or~anon Oss, The Netherlands. Other examples of implants that can be employed to make preloaded implantation devices according to the invention are oestradiol implants such as Riselle~, Meno-Implant, contraceptive implants such as Implanon~, or other hormonal implants such as testosterone implants. The device of the present invention, besides being suitable for introducing hormonal implants can also be employed for implants containing other active substances than hormones, and can be employed for implantation in other types of tissue beyond lipid tissue.
As will be clear from the above, with the present invention it is sought to provide an implantation device which can be preloaded, thus making it possible to avoid the step of loading the device with the implant during use, but at the same time has the possibility of being provided with provisions that require the free displaceability of the plunger, such as a plunger which blends with the tip o f the needle, so as to avoid undue damage to the patient's tissue.
This object is fulfilled by the invention. To this end, the invention consists therein, that in an implantation device of the above-identified, preloadable type, the chamber is positioned r adiallv outside the channel and has a directly or indirectly open connection to the channel, the plunger being capable of closing off and opening up the chamber by bein<T displaced.
Although benefits of the present invention can be enjoyed in the case of implantation devices that neither have a chamfered needle tip, nor a chamfered plunger tip, it will be clear that it is preferred according to the invention to have such provisions. In that respect, the invention provides a particular improvement on implantation devices such as described in EP 564 038, US 3,921,632.
Essentially, this is the type of devices which comprises a hollow needle with a chamfered tip profile and a body adjoining the needle part, the body comprising (a) an elongated part extending along the same axis as the needle, (b) a plunger that can be displaced within the elongated pan and the needle, the plunger having a chamfered tip profile capable of blending with the needle tip profile, wherein the periphery of the plunger defines a channel in the elongated part, and (c) a chamber capable of holding an implant. The chamber of these known devices not being preloadable, the present invention solves the problem of how to provide a preloadable device without losing the strong; benefit of the chamfered plunger profile. As outlined above, the means to solve this problem is that the device is provided with a chamber that is positioned radially outside the channel and has a directly or indirectly open connection to the channel, whereby the plunger is capable of closing off and opening up the chamber by being displaced.
The closing ot~ an opening up of the chamber can be by simple displacement of the plun'.:er. l.e., the chamber has an opening of such dimensions at the side of the plunger that, when the plunger is pulled back to behind the chamber (i.e. is pulled to the rear end of the device, by which is meant the end facing away from the needle), an implant contained within the chamber will automatically fall into the plunger channel. It is also possible to make use of other forces than that of gravity, e.g. by providing the chamber, at the side facing away from the channel, with an elastic means such as a spring, which pushes the implant against the plunger when the chamber is closed off and which makes the implant be pushed from the chamber into the channel when the plunger has been pulled back. Other means for the closing ofd of the chamber than just the plunger can be provided. Thus, other possibilities include a chamber closed off by an additional closing means, such as a door which automatically opens upon full withdrawal of the plunger, or any suitable mechanical, electronic or optical means steering the opening up of the chamber so that an implant contained therein can be displaced into the channel on or after the moment that the required space therein has become available by withdrawal of the plunger.
The requirement of the plun~,;er being capable of closing off' and opening up the chamber by being displaced not only refers to the way the open connection between the chamber and the channel has been made, it also refers to the longitudinal position of the chamber and the length of the plunger. It will be clear to the person of ordinaw skill in the art, that the plunger should be long enough to be pulled back to behind the chamber, and that it is preferred for the chamber to be at a sufficiently large distance from the rear end of the device so as to allow the plunger to be pulled back sufhicientlv and still be contained within the body of the device.
S
The device may contain suitable means to ensure that when the plunger is pushed fully into the needle, the chamfered needle point and the chamfered end of the mandrel coincide precisely. Possible means for providing this include a plunger end (i.e. at the side facing away from the needle) of in itself conventional type, which has a lamer diameter than the plunger channel, and thus will prevent the plunger from beinv; pushed forward any further than to the point at which said plunger end bumps against the plunger channel. Other means include a protrusion on the plunger and corresponding insertion in the wall of the plunger channel, or vice-versa, designed at such a position that when the plunger has been pushed forward to the 1S desired distance, the protrusion will be fixed into the insertion (comparable to a principle known from an unrelated art, viz. that of well-known ball-points of the BIC~ type).
As mentioned above, the chamber has a position radially outside the channel.
In ~~eneral, this means that the chamber has a position which, when the device is being used to administer an implant, can be described as being "above" the channel.
By virtue of the direct or indirect open connection of the chamber to the channel, an implant contained within the chamber will actually fall into the channel (as a result of the action of gravity) when the plunger has been withdrawn (pulled backwards) 2S so as to free the part of the channel directly underneath the chamber.
Other embodiments. though, are not to be excluded, e.g. a chamber which has a position which, upon use of the device, can be described as being "underneath" the channel and which comprises a spring or the like which may forward an implant into the channel.
In the case of a needle having the, most preferable, chamfered tip and associated chamfered plunger, the device is asymmetric in respect of a virtual central axis.
Thus a "bottom" and a "top" side of the device can be defined. In respect thereof, a preferred embodiment is as follows. Considering that the point of the chamfered S needle, and consequently also the point of the chamfered plunger, preferably are situated at the bottom side, it is preferred for the chamber capable of holding the implant to be situated at the top side.
The component parts of the device according to the invention and the feeding of a preloaded implant is further explained hereinafter with reference to the schematic drawings.
The figures each depict, in longitudinal cross-section, a device according to the invention. The reference signs in each of the figures having the same meaning, all of the fi~,;ures display an implantation device (I) having a hollow needle (2) and a body (3) adjoining the needle (2) the body comprising an elongated pan (4) extending along the same axis as the needle (2), a plunger (5) that can be displaced within the elongated part (4) and the needle (2), the periphery of the plunger defining a channel (G) in the elongated part (4), and a chamber (7) capable of holding an implant (8).
In FIG.1 a device ( 1 ) is shown in which the chamber (7) containing the implant (8) is in the closed-off position. FIG.2 shows a device ( 1 ) in which the chamber (7) has been opened up by pulling back the plunger (5) and the implant (8) has been fed into the channel (6). FIG.3 is incorporated to show the further operation of the device ( I ), viz. the pushing forward of the implant (8) by means of the plunger (5).
The components of the device are generally made of a hard material, for example stainless steel. Certain parts of the device may also be made of a suitable plastic, for example a hard type of PVC, certain nylons, PTFE, acrylates such as PPMA, polypropene, polystyrene, polycarbonate or polyoxymethylene. Preferred synthetic materials are those that are sterilisable, more particularly those that may withstand y-sterilisation. Such materials are known to the person of ordinary skill in the art.
Preferred synthetic materials are ABS (terpolymer of acrylonitrile, butadiene, and styrene) and SAN (copolymer of styrene and acrylonitrile). Without excluding the possibilities of using other than conventional materials for the needle part and said elongated part, or at least the distal parts thereof, these are generally made of metal, preferably stainless steel. The implantation devices of the invention can be manufactured using conventional techniques known to the person skilled in the art.
The body, which may serve as a handle part or may comprise an additional handle part, is thicker than the needle part and may be tubular, but it may also have a different cross section. The handle part should, of course, have a shape such that the device can easily be handled for the purpose for which the device is intended.
Thus, recesses can be provided in which the fingers, for example thumb and index finer, fit in order to enable the device to be held firmly during use.
The implants to be contained witi>in the chamber, and, consequently, the chamber itself, may have any shape. A frequently occurring shape is that of a rod of cylindrical or rectangular cross-section, such as in the case of an implantation tablet which contains oestradiol and which is made under the brand name Dimenformon by N. V. Or~anon Oss, The Netherlands. Other examples of implants that can be employed to make preloaded implantation devices according to the invention are oestradiol implants such as Riselle~, Meno-Implant, contraceptive implants such as Implanon~, or other hormonal implants such as testosterone implants. The device of the present invention, besides being suitable for introducing hormonal implants can also be employed for implants containing other active substances than hormones, and can be employed for implantation in other types of tissue beyond lipid tissue.
Claims (3)
1. An implantation device (1) comprising a hollow needle (2) and a body (3) adjoining the needle, the body (3) comprising an elongated part (4) extending along the same axis as the needle (2), a plunger (5) that can be displaced within the elongated part (4) and the needle (2), the periphery of the plunger (5) defining a channel (6) in the elongated part (4), and a chamber (7) capable of holding an implant (8), characterized in that the chamber (7) is positioned radially outside the channel (6) and has a directly or indirectly open connection to the channel (6), the plunger (5) being capable of closing off and opening up the chamber (7) by being displaced.
2. An implantation device (1) comprising a hollow needle (2) having a chamfered tip profile and a body (3) adjoining the needle (2), the body (3) comprising an elongated part (4) extending along the same axis as the needle (2), a plunger (5) that can be displaced within the elongated part (4) and the needle (2), the plunger (5) having a chamfered tip profile capable of blending with the needle tip profile, wherein the periphery of the plunger (5) defines a channel (6) in the elongated part (4), and a chamber (7) capable of holding an implant (8), characterized in that the chamber (7) is positioned radially outside the channel (6) and has a directly or indirectly open connection to the channel (6), the plunger (5) being capable of closing off and opening up the chamber (7) by being displaced.
3. An implantation device according to claim 1 or 2, characterized by being loaded with an implant (8) held in the chamber (7).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97201891.5 | 1997-06-20 | ||
EP97201891 | 1997-06-20 | ||
PCT/EP1998/003712 WO1998058698A1 (en) | 1997-06-20 | 1998-06-16 | Preloaded implantation device |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2294841A1 true CA2294841A1 (en) | 1998-12-30 |
Family
ID=8228465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002294841A Abandoned CA2294841A1 (en) | 1997-06-20 | 1998-06-16 | Preloaded implantation device |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0989880A1 (en) |
JP (1) | JP2002504844A (en) |
KR (1) | KR20010013962A (en) |
CN (1) | CN1177627C (en) |
AU (1) | AU738006B2 (en) |
BR (1) | BR9810180A (en) |
CA (1) | CA2294841A1 (en) |
HU (1) | HU222896B1 (en) |
IL (1) | IL133379A0 (en) |
NO (1) | NO996272D0 (en) |
PL (1) | PL187304B1 (en) |
TR (1) | TR199903143T2 (en) |
WO (1) | WO1998058698A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1545705A4 (en) | 2000-11-16 | 2010-04-28 | Microspherix Llc | Flexible and/or elastic brachytherapy seed or strand |
TWI434676B (en) | 2004-03-19 | 2014-04-21 | Merck Sharp & Dohme | X-ray visible drug delivery device |
NZ569202A (en) | 2006-01-19 | 2010-03-26 | Organon Nv | Kit for and method of assembling an applicator for inserting an implant |
DE102010013898A1 (en) * | 2010-04-01 | 2011-10-06 | Acino Ag | Implant cannula with implant and method for attaching implants in an injection cannula |
IT1405424B1 (en) * | 2011-02-25 | 2014-01-10 | Thd Spa | DEVICE FOR IMPLANTING A PROSTHESIS IN A FABRIC |
US9585672B2 (en) | 2011-02-25 | 2017-03-07 | Thd S.P.A. | Device for implanting a prosthesis in a tissue |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
CN212465989U (en) * | 2019-08-02 | 2021-02-05 | 华广生技股份有限公司 | Physiological signal sensing device |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1798766A (en) * | 1925-03-30 | 1931-03-31 | Ig Farbenindustrie Ag | Manufacture of active adsorbents |
US1789766A (en) * | 1925-07-30 | 1931-01-20 | Radium Emanation Corp | Surgical instrument for implanting capillary seeds containing radium emanation |
DE806702C (en) * | 1948-10-02 | 1951-06-18 | Dr Med Hermann Brune | Device for introducing solid medicaments into the human body or under the skin of the same |
US2751907A (en) * | 1953-09-18 | 1956-06-26 | Bishop & Co Platinum Works J | Pellet injector |
GB1525841A (en) * | 1976-05-18 | 1978-09-20 | Hundon Forge Ltd | Drug implanters |
US4661103A (en) * | 1986-03-03 | 1987-04-28 | Engineering Development Associates, Ltd. | Multiple implant injector |
GB2199247B (en) * | 1986-11-29 | 1990-06-20 | Femcare Ltd | Improvements in or relating to subcutaneous implantation equipment |
AU652984B2 (en) * | 1992-01-14 | 1994-09-15 | Endo Pharmaceuticals Solutions Inc. | Preparation of homogeneous hydrogel copolymers |
NL9200581A (en) * | 1992-03-30 | 1993-10-18 | Akuaba B V | IMPLANT DEVICE. |
-
1998
- 1998-06-16 AU AU82166/98A patent/AU738006B2/en not_active Ceased
- 1998-06-16 KR KR1019997011988A patent/KR20010013962A/en not_active Ceased
- 1998-06-16 JP JP50376599A patent/JP2002504844A/en active Pending
- 1998-06-16 EP EP98932172A patent/EP0989880A1/en not_active Withdrawn
- 1998-06-16 IL IL13337998A patent/IL133379A0/en not_active IP Right Cessation
- 1998-06-16 BR BR9810180-3A patent/BR9810180A/en not_active Application Discontinuation
- 1998-06-16 HU HU0003052A patent/HU222896B1/en not_active IP Right Cessation
- 1998-06-16 WO PCT/EP1998/003712 patent/WO1998058698A1/en not_active Application Discontinuation
- 1998-06-16 TR TR1999/03143T patent/TR199903143T2/en unknown
- 1998-06-16 CA CA002294841A patent/CA2294841A1/en not_active Abandoned
- 1998-06-16 CN CNB988063255A patent/CN1177627C/en not_active Expired - Fee Related
- 1998-06-16 PL PL98337575A patent/PL187304B1/en not_active IP Right Cessation
-
1999
- 1999-12-17 NO NO996272A patent/NO996272D0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1177627C (en) | 2004-12-01 |
IL133379A0 (en) | 2001-04-30 |
CN1260728A (en) | 2000-07-19 |
AU8216698A (en) | 1999-01-04 |
TR199903143T2 (en) | 2000-07-21 |
HU222896B1 (en) | 2003-12-29 |
NO996272L (en) | 1999-12-17 |
BR9810180A (en) | 2000-08-08 |
HUP0003052A2 (en) | 2001-01-29 |
HUP0003052A3 (en) | 2001-02-28 |
PL337575A1 (en) | 2000-08-28 |
EP0989880A1 (en) | 2000-04-05 |
WO1998058698A1 (en) | 1998-12-30 |
PL187304B1 (en) | 2004-06-30 |
NO996272D0 (en) | 1999-12-17 |
KR20010013962A (en) | 2001-02-26 |
AU738006B2 (en) | 2001-09-06 |
JP2002504844A (en) | 2002-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0354918B1 (en) | Injector for implanting multiple pellet medicaments | |
FI110577B (en) | An implant | |
US5800390A (en) | Equipment for intracerebral administration of preparations | |
US8353863B2 (en) | Skin penetrating device and method for subcutaneous solid drug delivery | |
Blackshear | Implantable drug-delivery systems | |
AU742061B2 (en) | Device for local administration of solid and semisolid formulations, sustained-release formulations for parenteral administration and method of preparation | |
HU199696B (en) | Implement for injecting implants | |
JP2001527435A (en) | Needle | |
JP2001502937A (en) | Medical devices for placement of solid materials | |
BRPI0408577B1 (en) | device, method and system for implanting at least one object under a patient's skin | |
JP2012020189A (en) | Device for injecting pharmaceutical active factor | |
AU738006B2 (en) | Preloaded implantation device | |
TW202203993A (en) | Patch pump, needle assembly and patch pump operating method | |
MXPA99011692A (en) | Preloaded implantation device | |
Lax et al. | A simple method for oral administration of drugs in solid form to fully conscious rats | |
US7083607B2 (en) | Injection device and method for injecting capsules | |
CZ463599A3 (en) | Implantation equipment | |
US20230149635A1 (en) | Applicator for Implant Insertion | |
GB2475932A (en) | Disposable catheter with reinforcement rod | |
CN100387312C (en) | Device for injecting solid substance into subcutaneous tissue | |
JPH0313322Y2 (en) | ||
TWI228425B (en) | Device capable of injecting solid substance into subcutaneous tissue | |
JPH0586238B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |